Corrigendum to “Psoriatic arthritis disease activity during pregnancy and the first-year postpartum” [Semin. Arthritis Rheum. 46 (6) (2017) 740–745](S0049017217300379)(10.1016/j.semarthrit.2017.01.002);Psoriatic arthritis disease activity during pregnancy and the first-year postpartum

Seminars in Arthritis and Rheumatism

Volumn 46, Issue 6, 2017, Pages 740-745

  Polachek, Ari ^a   Li, Suzanne ^a   Polachek, Inbal Shlomi ^b   Chandran, Vinod ^c,d   Gladman, Dafna ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Birth; Gestation; Joints; Psoriatic arthritis; Skin; Treatment

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LIVE BIRTH; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS AREA AND SEVERITY INDEX; PSORIATIC ARTHRITIS; PUERPERIUM; RETROSPECTIVE STUDY; FACTUAL DATABASE; PREGNANCY COMPLICATION; SEVERITY OF ILLNESS INDEX;

ADULT; ARTHRITIS, PSORIATIC; DATABASES, FACTUAL; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; SEVERITY OF ILLNESS INDEX;

EID: 85011958828     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2018.11.001     Document Type: Erratum

References (32)

1. Helmick, C.G., Lee-Han, H., Hirsch, S.C., Baird, T.L., Bartlett, C.L., Prevalence of psoriasis among adults in the U.S.: 2003–2006 and 2009–2010 National Health and Nutrition Examination Surveys. Am J Prev Med 47 (2014), 37–45.
2. Mease, P., Gladman, D., Papp, K., Khraishi, M.M., Thaçi, D., Behrens, F., et al. Prevalence of rheumatologist diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 69 (2013), 729–735.
3. Gladman, D.D., Antoni, C., Mease, P., Clegg, D.O., Nash, P., Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64:Suppl. 2 (2005), ii14–ii17.
4. Kammer, G.M., Soter, N.A., Gibson, D.J., Schur, P.H., Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 9 (1979), 75–97.
5. Scarpa, R., Oriente, P., Pucino, A., Torella, M., Vignone, L., Riccio, A., et al. Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23 (1984), 246–250.
6. Veale, D., Rogers, S., Fitzgerald, O., Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 33 (1994), 133–138.
7. Jones, S.M., Armas, J.B., Cohen, M.G., Lovell, C.R., Evison, G., McHugh, N.J., Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33 (1994), 834–839.
8. Ostenson, M., Husby, G., A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 26 (1983), 1155–1159.
9. Barret, J.H., Brennan, P., Fiddler, M., Silman, J.A., Does rheumatoid arthritis remit during pregnancy and relapse postpartum? results from a nationwide study in the united kingdom performed prospectively from late pregnancy. Arthritis Rheum 42 (1999), 1219–1227.
10. De Man, Y.A., Dolhain, R.J., van de Geijn, F.E., Willemsen, S.P., Hazes, J.M., Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 59 (2008), 1241–1248.
11. Ostensen, M., Husby, G., Romberg, O., Ankylosing spondylitis and mother hood. Arthritis Rheum 25 (1982), 140–143.
12. Ostensen, M., Ostensen, H., Ankylosing spondylitis—the female aspect. J Rheumatol 25 (1998), 120–124.
13. Ostensen, M., The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol 28 (1992), 235–237.
14. Murase, J.E., Chan, K.K., Garite, T.J., Cooper, D.M., Weinstein, G.D., Hormonal effect on psoriasis in pregnancy and postpartum. Arch Dermatol 141 (2005), 601–606.
15. Raychaudhuri, S.P., Navare, T., Gross, J., Raychaudhuri, S.K., Clinical course of psoriasis during pregnancy. Int J Dermatol 42 (2003), 518–520.
16. Ostensen, M., Pregnancy in psoriatic arthritis. Scand J Rheumatol 17 (1988), 67–70.
17. Gladman, D.D., Shuckett, R., Russell, M.L., Thorne, J.C., Schachter, R.K., Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62 (1987), 127–141.
18. Gladman, D.D., Chandran, V., Obsevational cohort studies:lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 50 (2011), 25–31.
19. Rahman, P., Gladman, D.D., Cook, R.J., Zhou, Y., Young, G., Salonen, D., Radiological assessment in psoriatic arthritis. Br J rheumatol 37 (1998), 760–765.
20. Coates, L.C., Fransen, J., Helliwell, P.S., Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69 (2010), 48–53.
21. Ostensen, M., Fuhrer, L., Mathieu, R., Seitz, M., Villiger, P.M., A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis 63 (2004), 1212–1217.
22. Dessinioti, C., Stefanaki, I., Stratigos, A.J., Kostaki, M., Katsambas, A., Antoniou, C., Pregnancy during adalimumab use for psoriasis. J Eur Acad Dermatol Venereol 25 (2011), 738–739.
23. Chambers, C.D., Johnson, D.L., Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy. Birth Defects Res A Clin Mol Teratol 94 (2012), 607–611.
24. Chambers, C., Jonhson, D., Jones, K., Pregnancy outcomes in women exposed to etanercept: the OTIS autoimune diseases in pregnancy project. J Am Acad Dermatol, 56, 2007, AB10.
25. Götestam, S.C., Hoeltzenbein, M., Tincani, A., Fischer-Betz, R., Elefant, E., Chambers, C., et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75 (2016), 795–810.
26. Gossec, L., Smolen, J.S., Gaujoux-Viala, C., Ash, Z., Marzo-Ortega, H., van der Heijde, D., et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 71 (2012), 4–12.
27. Ritchlin, C.T., Kavanaugh, A., Gladman, D.D., Mease, P.J., Helliwell, P., Boehncke, W.H., et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 68 (2009), 1387–1394.
28. Boyd, A.S., Morris, L.F., Phillips, C.M., Menter, M.A., Psoriasis and pregnancy: hormone and immune system interaction. Int J Dermatol 35 (1996), 169–172.
29. Mowad, C.M., Margolis, D.J., Halpern, A.C., Suri, B., Synnestvedt, M., Guzzo, C.A., Hormonal influences on women with psoriasis. Cutis 61 (1998), 257–260.
30. Santner-Nanan, B., Peek, M.J., Khanam, R., Richarts, L., Zhu, E., Fazekas de St Groth, B., et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 183 (2009), 7023–7030.
31. Holland, D., Bretscher, P., Russell, A.S., Immunologic and inflammatory responses during pregnancy. J Clin Lab Immunol 14 (1984), 177–179.
32. Nelson, J.L., Hughes, K.A., Smith, A.G., Nisperos, B.B., Branchaud, A.M., Hansen, J.A., Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329 (1993), 466–471.